We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+10.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$3.77M
Cap. Flow
-$171K
Cap. Flow %
-0.17%
Top 10 Hldgs %
22.09%
Holding
226
New
42
Increased
62
Reduced
36
Closed
61

Top Buys

Rank Stock Value
1
NVAX icon
Novavax
NVAX
+$1.85M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$1.67M
3
TSVT
2seventy bio
TSVT
+$1.59M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$1.37M
5
ADCT icon
ADC Therapeutics
ADCT
+$1.19M

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$12.8M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$2.1M
3
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$2.08M
4
WBA
Walgreens Boots Alliance
WBA
+$1.6M
5
SNY icon
Sanofi
SNY
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 56.8%
2 Real Estate 15.08%
3 Financials 8.32%
4 Energy 6.75%
5 Industrials 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RITM icon
1
Rithm Capital
RITM
$5.2B
$4.02M 3.97%
491,699
+54,680
+13% +$456K
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.9M 2.87%
25,500
-4,938
-16% -$410K
COOP
3
DELISTED
Mr. Cooper
COOP
$2.28M 2.25%
56,790
+4,050
+8% +$171K
GSK icon
4
GSK
GSK
$104B
$2.14M 2.12%
61,000
-9,000
-13% -$300K
PRCT icon
5
Procept Biorobotics
PRCT
$1.09B
$2.08M 2.05%
50,000
– –
EFC
6
Ellington Financial
EFC
$1.7B
$2.04M 2.02%
165,154
+36,275
+28% +$473K
LKFT
7
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.97B
$1.89M 1.86%
42,500
+12,500
+42% +$526K
PFSI icon
8
PennyMac Financial
PFSI
$4.43B
$1.76M 1.74%
31,123
– –
TSVT
9
DELISTED
2seventy bio
TSVT
$1.69M 1.67%
180,000
+113,000
+169% +$1.59M
MFA
10
MFA Financial
MFA
$960M
$1.56M 1.54%
158,230
+25,000
+19% +$251K
ADAM
11
Adamas Trust
ADAM
$807M
$1.53M 1.51%
148,933
+58,348
+64% +$622K
AUPH icon
12
Aurinia Pharmaceuticals
AUPH
$2.05B
$1.52M 1.5%
352,500
+193,000
+121% +$1.12M
CHRS icon
13
Coherus Oncology
CHRS
$216M
$1.49M 1.47%
187,500
+134,500
+254% +$1.03M
VRNA
14
DELISTED
Verona Pharma
VRNA
$1.44M 1.42%
55,000
+15,000
+38% +$200K
BCRX icon
15
BioCryst Pharmaceuticals
BCRX
$2.36B
$1.44M 1.42%
125,000
+55,000
+79% +$686K
BIO icon
16
Bio-Rad Laboratories Class A
BIO
$8.15B
$1.43M 1.41%
3,400
+1,700
+100% +$686K
AIRS icon
17
AirSculpt Technologies
AIRS
$314M
$1.33M 1.32%
360,000
+253,000
+236% +$1.17M
ISRG icon
18
Intuitive Surgical
ISRG
$122B
$1.33M 1.31%
5,000
– –
ALNT icon
19
Allient
ALNT
$1.49B
$1.31M 1.29%
37,500
– –
AVAV icon
20
AeroVironment
AVAV
$7.2B
$1.28M 1.27%
15,000
– –
ELAN icon
21
Elanco Animal Health
ELAN
$12.9B
$1.25M 1.24%
102,500
+25,000
+32% +$312K
RARE icon
22
Ultragenyx Pharmaceutical
RARE
$2.88B
$1.25M 1.24%
+27,000
New +$1.06M
STWD icon
23
Starwood Property Trust
STWD
$6.3B
$1.19M 1.18%
65,000
– –
FLGT icon
24
Fulgent Genetics
FLGT
$573M
$1.18M 1.16%
39,500
+9,000
+30% +$322K
ARQT icon
25
Arcutis Biotherapeutics
ARQT
$3.56B
$1.16M 1.15%
+78,500
New +$1.37M
1
2 3 4 5

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, AlphaCentric Advisors held 226 positions worth $101M, up 3.9% from $97.4M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors's Q4 2022 filing shows 42 new, 62 increased, 36 reduced and 61 closed positions. Its largest new stake was Novavax: 105,000 shares worth $1.08M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 44% a quarter earlier, followed by Real Estate and Financials.

  • AlphaCentric Advisors's largest Q4 2022 buy was Novavax: 105,000 shares worth $1.08M.
  • AlphaCentric Advisors added most to 2seventy bio in Q4 2022, an estimated $1.59M increase.
  • AlphaCentric Advisors's biggest Q4 2022 reduction was Walgreens Boots Alliance, cutting an estimated $1.6M.
  • AlphaCentric Advisors fully exited iShares 1-3 Year Treasury Bond ETF in Q4 2022, selling an estimated $12.8M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $101M portfolio in Q4 2022.
  • AlphaCentric Advisors opened 42 new positions and closed 61 in Q4 2022.
  • AlphaCentric Advisors's portfolio value rose 3.9% quarter-over-quarter to $101M.

Based on AlphaCentric Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.